Devonian Health Group is trading 12.64% up now at $9.00, with no verified September 9, 2026 company-specific announcement or explicit catalyst identified for the advance.
- Broader markets are weaker as escalating U.S.–Iran tensions push Brent crude toward $100 and reduce risk appetite.
- Devonian Health Group is moving against that trend.
- The latest identified company news is September 1 manufacturing validation for Thykamine, which does not directly explain today’s movement.